on Laxxon Medical
Laxxon Medical to Engage in World Orphan Drug Congress USA 2024
Laxxon Medical, a company recognized for its 3D screen printing technology in pharmaceuticals, announced its participation in the upcoming World Orphan Drug Congress USA 2024. This major event will take place from April 23-25 in Boston, Massachusetts.
Dr. Catherine Gatza, Vice President of Regulatory Affairs, is set to represent Laxxon Medical at the conference. This venue gathers notables from the pharmaceutical and biotech industry, along with regulatory bodies, patient advocacy groups, and investors to discuss innovations in orphan drug development and enhancing access to crucial therapies.
R. E.Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Laxxon Medical news